Impaired endothelial-dependent and endothelium-independent vasodilatation in patients with thromboangiitis obliterans

M Brodmann1, F Hafner, T Gary

  • 1Department of Internal Medicine, Division of Angiology, Medical University Graz, Graz, Austria. marianne.brodmann@medunigraz.at

Insights

Endothelial dysfunction, specifically impaired nitroglycerin-induced vasodilation, is significant in thrombangitis obliterans (TAO). This suggests both endothelium-dependent and independent mechanisms contribute to TAO pathogenesis.

Area of Science:

  • Vascular Biology
  • Cardiovascular Medicine
  • Pathophysiology

Background:

  • Endothelial dysfunction is a critical factor in atherosclerosis development.
  • Investigating endothelial dysfunction in thrombangitis obliterans (TAO) is crucial for understanding its pathogenesis.

Purpose of the Study:

  • To evaluate endothelial dysfunction in patients with TAO using the Celermajer noninvasive technique.
  • To assess the roles of endothelium-dependent and independent vasodilation in TAO.

Main Methods:

  • Compared 36 TAO patients with 30 healthy controls.
  • Utilized high-frequency ultrasound to measure flow-mediated (endothelium-dependent) and nitroglycerin-induced (endothelium-independent) vasodilation.

Main Results:

  • TAO patients exhibited statistically significant reduced nitroglycerin-induced vasodilation compared to controls.
  • Flow-mediated dilation was lower in TAO patients, though not statistically significant.

Conclusions:

  • Both endothelium-dependent and independent mechanisms are implicated in TAO.
  • Impaired endothelium-independent vasodilation plays a more significant role in TAO than previously recognized.
Abstract

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...